Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. - Wikidata - wikimedia - TriplyDB

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.

http://www.wikidata.org/entity/Q44467041

about

Mediators of inflammation in polycystic ovary syndrome in relation to adiposity Ischemic heart disease in women: a focus on risk factors Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists Complications and challenges associated with polycystic ovary syndrome: current perspectives Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.The metabolic syndrome Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline Polycystic ovarian syndrome: diagnosis and management.Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys.Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study.Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.The American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea.Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.Is interleukin-18 associated with polycystic ovary syndrome?Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).Epidemiology, diagnosis, and management of polycystic ovary syndrome IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance.Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome Comparison of Biomedical Variables in PCOS Patients with Normal Iranian Women Ovarian hypertension: polycystic ovary syndrome.Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea.Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.Combined oral contraceptives in the treatment of polycystic ovary syndrome.Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.Medical management of metabolic dysfunction in PCOS.Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome Evidence for statin therapy in polycystic ovary syndrome.Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome.Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art.Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.Risk of cardiovascular events in patients with polycystic ovary syndrome.Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study Indices of low-grade inflammation in polycystic ovary syndrome.Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification

P2860

Q21296837-2774015B-5F4A-4A20-A758-16F65D4A9920 Q22251459-E074302D-425D-4088-9156-107155EACD8D Q26749044-79C96344-7F22-4B14-B471-5D20DDB31EE1 Q26799566-096C760E-7DFE-4E07-A475-E398D01FB427 Q27021307-80FBC704-BF08-4DAA-AD76-EB4DAF57C835 Q28390200-D941F23D-53FE-4B16-8001-DF8161DF2188 Q33445558-677AE001-FF25-411D-9F5D-B81E62B9401B Q33569142-82AF5596-189C-4441-B612-6F011E837D11 Q33587845-EDF772E5-8B1F-46AB-8503-873885E0F943 Q33723471-AF836FBB-6360-4D79-9E1A-117CFC4E3549 Q33784651-58DB6EEF-15DC-45F0-8DAD-20F86500D8B0 Q34047348-65671F7E-F790-4840-99FE-D16ED91ABDA5 Q34113211-1C791070-4970-4A22-B661-D2BB230F4130 Q34137763-0D842FFA-D9C9-4602-9AFB-E619B7B66A85 Q34421903-2661AB12-23A4-4B06-87F9-7DD14C51F577 Q34465368-176C3636-A422-4B3C-98A7-454752EEA237 Q34560258-C0C662EB-2828-418E-B0DD-061F837E4C16 Q34650147-25DBC971-DC4D-4BB8-AB20-6977077E6AF1 Q34658641-BDE7D71C-FD19-4C97-B253-A1A9B652B5D5 Q34908689-81D9F96A-7230-441B-858A-239EA01628B6 Q35108260-DF9D6309-48D2-4C8A-AA38-1F729D2322D9 Q35514992-AFC2B4FB-AA9C-4580-945A-CA8BE517EB49 Q35660296-63AF913D-76DD-4672-8D3B-EE53EE29004A Q35757344-A23A8E32-39F4-4F03-88A4-A0E0F9750F23 Q36058191-BF00646F-CBAB-425E-A35C-FCC71BC91B99 Q36080057-E12A7681-540C-4D4D-8060-012503605011 Q36106385-E4E30003-08C7-4845-8093-F88A3FDC1DF6 Q36132055-472F4E01-030A-44C4-A26E-07B5B45D3094 Q36208271-E4970BCA-2552-49F5-A0B3-37593CEF0407 Q36327934-BE4CC3E2-B160-456A-B9A3-D35B08E5B344 Q36378559-8F2F5CFA-AFB5-40BC-BE85-DBA9CB7963FC Q36433627-D2FB29FE-A03B-4E90-AD2F-CBC5158B3378 Q36480698-66E57479-E2F0-4294-9930-A195139A26BB Q36536790-31C70A9A-A20E-4B48-A61B-F2FDDC83F103 Q36593148-A124B7EC-A1FE-4D66-B348-B318D5F041B5 Q36638483-1777BC5B-B2AC-4622-814B-78D7B9E0A472 Q36666427-C6924EA7-3A09-41C5-AD5D-90A0849EAB5E Q36739203-ACB12C7D-C3D4-46DB-85E9-B88EB492C477 Q36812747-9C543825-1CEC-4592-B30D-B075224BA784 Q36814985-7BD3AABE-BD9F-4CC3-914C-6ABAC9B814C0

P2860

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.

http://www.wikidata.org/entity/Q44467041

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Prevalence and predictors of c ...... ith polycystic ovary syndrome.

@en

Prevalence and predictors of c ...... ith polycystic ovary syndrome.

@nl

type

label

Prevalence and predictors of c ...... ith polycystic ovary syndrome.

@en

Prevalence and predictors of c ...... ith polycystic ovary syndrome.

@nl

prefLabel

Prevalence and predictors of c ...... ith polycystic ovary syndrome.

@en

Prevalence and predictors of c ...... ith polycystic ovary syndrome.

@nl

P1433

Q44467041-6848C399-D4A9-4843-A374-E12A6B2A787E

P1476

Q44467041-F808BFC2-1B31-4B3F-AAD8-EC0DBB5AFA10

P2093

Q44467041-179AFF63-E7C4-48FF-8630-3F4D11DBF262

Q44467041-30708C25-C0BA-4DC0-9F58-46910A265CCF

Q44467041-5BCE53A6-608B-4234-B284-B78A3579281B

Q44467041-BEC61B0F-95ED-41E4-AF04-2F5AA9685C3E

Q44467041-D14E5053-4F08-4347-83B2-96A076733C7C

Q44467041-DBAF80B4-0A9B-4D51-BE9F-E2B1A09A96D2

P304

Q44467041-404BA8A6-9C31-4DCC-9DEA-059A8F420FC9

P31

Q44467041-C072BC65-A44A-4E23-8C86-52B766D86FC8

P356

Q44467041-6B541D3E-EA65-434E-80C2-F7617F2E3807

P407

Q44467041-634635EC-1FF1-428D-864C-52B7291739DB

P433

Q44467041-A5982811-3743-4C3E-8D63-81D39A3BCE74

P478

Q44467041-22D08E60-3104-496B-8324-5BC277FE9ADD

P577

Q44467041-52113B21-FFAF-426F-9C15-6B3C7092D78F

P5875

Q44467041-5F4A170B-AE01-48D9-9B76-AE18A6D596E6

P698

Q44467041-76B1A883-297D-412E-B447-22F24C506773

P921

Q44467041-60FDC127-D2BD-4BFD-8D0A-B8A5E48B1F23

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Prevalence and predictors of c ...... ith polycystic ovary syndrome.

@en

P2093

Ann L Oberg

http://www.w3.org/2001/XMLSchema#string

Daniel A Dumesic

http://www.w3.org/2001/XMLSchema#string

Lorraine A Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Patrick F Sheedy

http://www.w3.org/2001/XMLSchema#string

Rose C Christian

http://www.w3.org/2001/XMLSchema#string

Thomas Behrenbeck

http://www.w3.org/2001/XMLSchema#string

P304

2562-2568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2003-030334

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10723322

http://www.w3.org/2001/XMLSchema#string

P698

12788855

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome